secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rezolute, Inc. (RZLT)
CIK:        0001509261
Form:       8-K
Filed at:   2024-06-27T23:59:59+00:00
Accession:  0001104659-24-075387
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rezolute raises ~$67M through public offering and concurrent private placement
------------------------------------------------------------------------------

- Underwriters exercised over-allotment option for 1,786,589 shares at $4.00 each.
- Total offering: 13,036,589 shares plus pre-funded warrants for 3.75M shares; gross proceeds ~$67M.
- Concurrent private placement of 1.5M shares at $4.00/share for ~$6M in additional gross proceeds.
- Net proceeds will fund clinical R&D (RZ358 for hyperinsulinism) and working capital.
- Jefferies and Cantor acted as joint book-running managers for the public offering.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1509261/000110465924075387/0001104659-24-075387-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1509261/000110465924075387/tm2418270d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-075387

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer